Move Over SpaceX: These 2 Space Stocks Are Nipping at Its Heels

SpaceX’s post–mid-June IPO momentum is framed against competition in launches and satellite-to-surface broadband. The article highlights Rocket Lab’s reusable Electron (91 successful flights, 262+ satellites deployed) and an expected Neutron debut by year-end, alongside Rocket Lab’s planned ~$8B acquisition of Iridium to expand monetization of satellite communications. It also points to AST SpaceMobile’s developmental carrier partnerships (Verizon/AT&T) and forecasts for a 140% stop-line growth this year and 340% next year, targeting profitability by 2028, while noting the holding will be volatile.

Analysis

The market is likely over-indexing on “space internet” as a winner-take-all story. In reality, the near-term economics favor the companies that control distribution, spectrum access, and launch cadence, not the ones with the loudest narrative. That makes ASTS a high-beta optionality name rather than a clean fundamental comp; the real bear case is dilution and schedule slippage, not competitive saturation. For T, TMUS, and VZ, the first-order risk is not lost core wireless revenue, but margin leakage if they have to subsidize satellite access to defend churn.

RKLB looks better positioned structurally because it can monetize a broader stack than launch alone, but the valuation debate will hinge on whether Neutron becomes a credible medium-lift alternative on schedule. If first flights slip, the stock can de-rate quickly from “platform” to “pre-scale hardware” even if launch demand remains healthy. IRDM is a potential beneficiary only if any strategic transaction is real and financed; otherwise the market should treat that angle as noise until there is a filed deal and terms.

The contrarian view is that consensus is underestimating how much bargaining power incumbents retain: carriers can slow-roll partnerships, demand unattractive rev-share terms, and use satellite coverage mainly as a retention tool. The bigger upside in ASTS is not immediate revenue, but a reassessment of terminal value if commercialization actually proves cheap and repeatable. That thesis is falsified by launch delays, FCC/spectrum friction, or any evidence that customer acquisition costs and satellite replacement economics are worse than promised over the next 6-18 months.

Key Decisions for Investors

• ASTS: wait for confirmation of deployment cadence and funding clarity before buying. If the next 1-2 catalysts hit, use a 6-12 month call spread rather than stock to capture convexity while capping dilution risk.
• RKLB: accumulate on pullbacks as a medium-term 6-18 month position, but only if Neutron stays on track. Falsify on a meaningful launch-delay slip or backlog conversion slowdown.
• T / TMUS / VZ: do not short aggressively yet; treat them as monitored hedges. They become a short only if ASTS shows repeatable commercial traction and carrier economics start to imply material wholesale pricing pressure.
• IRDM: keep on watch for a verified transaction filing or financing details; until then, avoid trading the rumor. If a real deal appears, evaluate it as a spread/arb situation, not a directional conviction long.
• Pair-trade idea: long RKLB vs. a broad communications-services basket only if the market starts pricing in satellite optionality faster than launch execution. Stop out if execution slips or if ASTS/rival narratives fail to translate into backlog growth.